Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2246
|
183
|
0.700 |
None |
0.977 |
252 |
1
|
2008 |
2020 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2469
|
234
|
0.700 |
None |
0.957 |
180 |
5
|
2000 |
2020 |
Inflammatory Myofibroblastic Tumor
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
92
|
2
|
0.700 |
None |
0.966 |
116 |
2
|
1999 |
2019 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
980
|
85
|
0.610 |
None |
1.000 |
1 |
|
2009 |
2012 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3882
|
601
|
0.600 |
None |
0.990 |
1033 |
11
|
2007 |
2020 |
Ki-1+ Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
292
|
10
|
0.600 |
None |
0.973 |
360 |
4
|
1995 |
2020 |
Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
547
|
17
|
0.500 |
None |
1.000 |
17 |
|
2009 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6345
|
327
|
0.400 |
None |
0.983 |
58 |
1
|
2007 |
2020 |
Anaplastic Large Cell Lymphoma, ALK-Positive
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
25
|
|
0.400 |
None |
0.931 |
28 |
|
1999 |
2019 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1020
|
109
|
0.400 |
None |
1.000 |
19 |
|
2003 |
2018 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
1958
|
182
|
0.400 |
None |
0.947 |
18 |
|
2012 |
2019 |
hereditary neuroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
9
|
4
|
0.400 |
None |
0.933 |
15 |
4
|
2008 |
2018 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2274
|
203
|
0.400 |
None |
0.929 |
13 |
|
2012 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6500
|
2145
|
0.390 |
None |
0.900 |
9 |
|
2002 |
2019 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2890
|
352
|
0.390 |
None |
1.000 |
9 |
|
2015 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6481
|
2154
|
0.370 |
None |
1.000 |
7 |
|
2009 |
2018 |
ALK positive large B-cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
5
|
|
0.360 |
None |
1.000 |
6 |
|
2011 |
2017 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1293
|
193
|
0.350 |
None |
1.000 |
5 |
|
2012 |
2019 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
2991
|
283
|
0.320 |
None |
1.000 |
2 |
|
2011 |
2017 |
Neoplasms, Intracranial
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
131
|
4
|
0.320 |
None |
1.000 |
2 |
|
2012 |
2019 |
Inflammatory Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
183
|
|
0.320 |
None |
1.000 |
2 |
|
2012 |
2015 |
Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
471
|
223
|
0.310 |
None |
1.000 |
1 |
|
2011 |
2017 |
Ovarian Serous Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
90
|
|
0.310 |
None |
1.000 |
1 |
|
2016 |
2016 |
Plasma Cell Granuloma, Pulmonary
|
disease |
Respiratory Tract Diseases
|
Neoplastic Process
|
1
|
|
0.310 |
None |
1.000 |
1 |
|
2001 |
2011 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2217
|
1332
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2006 |